Average Co-Inventor Count = 7.54
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Kinnate Biopharma Inc. (7 from 14 patents)
2. Other (3 from 832,843 patents)
3. Cardurion Pharmaceuticals, LLC (2 from 10 patents)
4. Eli Lilly and Company (1 from 4,446 patents)
5. Takeda Pharmaceutical Company Limited (1 from 1,179 patents)
6. Ligand Pharmaceuticals, Inc. (1 from 134 patents)
15 patents:
1. 11814384 - Inhibtors of Raf kinases
2. 11753395 - Inhibitors of MET kinase
3. 11407737 - Inhibitors of RAF kinases
4. 11390618 - Inhibitors of cyclin-dependent kinases
5. 11345681 - Inhibitors of fibroblast growth factor receptor kinases
6. 11197858 - Substituted amines for treating cardiac diseases
7. 11098031 - Inhibitors of RAF kinases
8. 10894788 - Inhibitors of cyclin-dependent kinases
9. 10543212 - Substituted amines for treating cardiac diseases
10. 8138168 - Renin inhibitors
11. 7176224 - Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists
12. 6825222 - Modulators of peroxisome proliferator activated receptors
13. 6610696 - Modulators of peroxisome proliferator activated receptors
14. 6593493 - RXR modulators with improved pharmacologic profile
15. 6417212 - Modulators of peroxisome proliferator activated receptors